Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study

CONCLUSION: Results support the use of sacubitril/valsartan in Indian patients with chronic HF with reduced ejection fraction with treatment benefits similar to global PARADIGM-HF cohort.PMID:33357641 | PMC:PMC7772612 | DOI:10.1016/j.ihj.2020.09.016

Source: Indian Heart J - December 28, 2020 Category: Cardiology Authors: Anil Ranjeetmal Jain Rakesh Kumar Aggarwal Nanyam Srinivas Rao Gauri Billa Shankar Kumar Source Type: research